Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting.

Mandalakas, Anna M; Hesseling, Anneke C; Gie, Robert P; Schaaf, H S; Marais, Ben J; Sinanovic, Edina

Mandalakas, Anna M; Hesseling, Anneke C; Gie, Robert P; Schaaf, H S; Marais, Ben J; Sinanovic, Edina.

Affiliation

Mandalakas AM; Section on Retrovirology and Global Health, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA. anna.mandalakas@bcm.edu

Thorax ; 68(3): 247-55, 2013 Mar.

Article in En | MEDLINE | ID: mdl-22717944

Subject(s)

Decision Support Techniques; Models, Economic; Tuberculosis, Pulmonary/economics; Tuberculosis, Pulmonary/prevention & control; Antitubercular Agents/economics; Antitubercular Agents/therapeutic use; Child; Child, Preschool; Cost-Benefit Analysis; Humans; Infant; Interferon-gamma Release Tests/economics; Isoniazid/economics; Isoniazid/therapeutic use; Markov Chains; Tuberculin Test/economics; Tuberculosis, Pulmonary/diagnosis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Pulmonary / Decision Support Techniques / Models, Economic Type of study: Diagnostic_studies / Guideline / Health_economic_evaluation / Prognostic_studies Limits: Child / Child, preschool / Humans / Infant Language: En Journal: Thorax Year: 2013 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google